Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126475341 | 12647534 | 1 | I | 20160601 | 0 | 20160811 | 20160811 | DIR | 14.41 | YR | M | N | 66.20000 | KG | 20160808 | N | MD | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126475341 | 12647534 | 1 | PS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | 0 | 16230 | MG | ||||||||||
| 126475341 | 12647534 | 2 | SS | DOXORUBICIN HYDROCHLORIDE. | DOXORUBICIN HYDROCHLORIDE | 1 | 0 | 176 | MG | ||||||||||
| 126475341 | 12647534 | 3 | SS | ETOPOSIDE (VP-16) | ETOPOSIDE | 1 | 0 | 3674 | MG | ||||||||||
| 126475341 | 12647534 | 4 | SS | CYTARABINE. | CYTARABINE | 1 | 0 | 91440 | MG | ||||||||||
| 126475341 | 12647534 | 5 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | 0 | 524 | MG | ||||||||||
| 126475341 | 12647534 | 6 | SS | G-CSF (FILGRASTIM, AMGEN) | FILGRASTIM | 1 | 0 | 16840 | UG | ||||||||||
| 126475341 | 12647534 | 7 | SS | L-ASPARAGINASE | ASPARAGINASE | 1 | 0 | 14040 | IU | ||||||||||
| 126475341 | 12647534 | 8 | SS | LEUCOVORIN CALCIUM. | LEUCOVORIN CALCIUM | 1 | 0 | 522 | MG | ||||||||||
| 126475341 | 12647534 | 9 | SS | METHOTREXATE. | METHOTREXATE | 1 | 0 | 56657 | MG | ||||||||||
| 126475341 | 12647534 | 10 | SS | PEG-L-ASPARAGINASE (K-H) | PEGASPARGASE | 1 | 0 | 32882.5 | IU | ||||||||||
| 126475341 | 12647534 | 11 | SS | PREDNISONE. | PREDNISONE | 1 | 0 | 504 | MG | ||||||||||
| 126475341 | 12647534 | 12 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | 0 | 76.8 | MG |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126475341 | 12647534 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126475341 | 12647534 | Opportunistic infection | |
| 126475341 | 12647534 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126475341 | 12647534 | 1 | 20150625 | 0 | ||
| 126475341 | 12647534 | 2 | 20131104 | 0 | ||
| 126475341 | 12647534 | 3 | 20140620 | 0 | ||
| 126475341 | 12647534 | 4 | 20140509 | 0 | ||
| 126475341 | 12647534 | 5 | 20150427 | 0 | ||
| 126475341 | 12647534 | 6 | 20140526 | 0 | ||
| 126475341 | 12647534 | 7 | 20130420 | 0 | ||
| 126475341 | 12647534 | 8 | 20140601 | 0 | ||
| 126475341 | 12647534 | 9 | 20140530 | 0 | ||
| 126475341 | 12647534 | 10 | 20140509 | 0 | ||
| 126475341 | 12647534 | 11 | 20130219 | 0 | ||
| 126475341 | 12647534 | 12 | 20150625 | 0 |